
Treatment of DMD has evolved from supportive multidisciplinary care to multimodal disease-modifying treatment, including therapies that target the underlying molecular defect.

Treatment of DMD has evolved from supportive multidisciplinary care to multimodal disease-modifying treatment, including therapies that target the underlying molecular defect.

Duchenne muscular dystrophy (DMD) is a rare neuromuscular disease that continues to result in progressive loss of ambulation, respiratory failure, cardiomyopathy, and early mortality.

DMD is associated with a substantial and progressively increasing economic burden.